Consistent with the published studies which show that succinate accumulated in the synovial fluids from RA patients (32, 33), the finding of the role of succinate/NLRP3 inflammation signaling not only provides insight into the connection between inflammation and fibroblast activation but also reveals therapeutic targets for RA treatment. The gene discussed is NLRP3; the disease is rheumatoid arthritis.